Skip to Main Content

Paper Details

Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
11
2023
Author NameAffiliation
Matti AnnalaProstate Cancer Research Center, Tampere University and Tays Cancer Center
Cameron HerbertsUniversity of British Columbia
Paul Hamberg
Inge M van OortResearch Institute for Medical Innovation, Radboud University Medical Center
Niven MehraResearch Institute for Medical Innovation, Radboud University Medical Center
Alexander W WyattUniversity of British Columbia
Alexander W Wyatt
  • 1 - 7

Datasets

Release 1.2